FDA NDC Directory · JSON-LD · Markdown

carbamazepine

NDC 68382-556 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerZydus Pharmaceuticals (USA) Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205571
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsCARBAMAZEPINE (200 mg/1)
Marketing started20190312
Package count4

External sources

Source: openFDA. Public-domain (CC0).